Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the<i>TP53</i>gene on survival in patients with advanced ovarian carcinoma
Yun Wang(Sun Yat-sen University), Åslaug Helland(Oslo University Hospital), Magali Olivier(Centre international de recherche sur le cancer), Claes G. Tropé, M. Baekelandt(Norwegian Cancer Society), Ruth Holm(University of Aleppo), Pedro Kringen(Norwegian Cancer Society), Pierre Hainaut(Université Grenoble Alpes), Anne‐Lise Børresen‐Dale(Oslo University Hospital), Jahn M. Nesland(University of Oslo), Hanne Skomedal(University of Oslo), Vera M. Abeler(Oslo University Hospital), Gunnar B. Kristensen(Oslo University Hospital)
Cited by 51
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
|Cold Spring Harbor Perspectives in Biology|2009|2.2k
The Life History of 21 Breast Cancers
|Cell|2012|1.5k